
[ Thu, Jan 16th ]: BBC
[ Thu, Jan 16th ]: cryptonews
[ Thu, Jan 16th ]: Slate
[ Thu, Jan 16th ]: CNN
[ Thu, Jan 16th ]: BBC
[ Thu, Jan 16th ]: Yahoo
[ Thu, Jan 16th ]: Newsweek
[ Thu, Jan 16th ]: Firstpost
[ Thu, Jan 16th ]: cryptonews
[ Thu, Jan 16th ]: Newsweek
[ Thu, Jan 16th ]: Wired
[ Thu, Jan 16th ]: Scroll
[ Thu, Jan 16th ]: UPI
[ Thu, Jan 16th ]: NDTV
[ Thu, Jan 16th ]: MSN
[ Thu, Jan 16th ]: MSN
[ Thu, Jan 16th ]: MSN
[ Thu, Jan 16th ]: MSN
[ Thu, Jan 16th ]: MSN
[ Thu, Jan 16th ]: MSN

[ Wed, Jan 15th ]: deseret
[ Wed, Jan 15th ]: cnycentral
[ Wed, Jan 15th ]: deseret
[ Wed, Jan 15th ]: NDTV
[ Wed, Jan 15th ]: Indiatimes
[ Wed, Jan 15th ]: katv
[ Wed, Jan 15th ]: techUK
[ Wed, Jan 15th ]: Forbes
[ Wed, Jan 15th ]: KIMT
[ Wed, Jan 15th ]: Forbes
[ Wed, Jan 15th ]: AOL
[ Wed, Jan 15th ]: Nature
[ Wed, Jan 15th ]: Reuters
[ Wed, Jan 15th ]: Yahoo
[ Wed, Jan 15th ]: NDTV
[ Wed, Jan 15th ]: timesnownews
[ Wed, Jan 15th ]: Computerworld
[ Wed, Jan 15th ]: Reuters
[ Wed, Jan 15th ]: CNET
[ Wed, Jan 15th ]: Newsweek
[ Wed, Jan 15th ]: earth
[ Wed, Jan 15th ]: MSN
[ Wed, Jan 15th ]: MSN
[ Wed, Jan 15th ]: Tuko
[ Wed, Jan 15th ]: Reuters
[ Wed, Jan 15th ]: MSN
[ Wed, Jan 15th ]: MSN
[ Wed, Jan 15th ]: MSN
AbbVie and Simcere Zaiming link to develop trispecific antibody


🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
The humanised trispecific antibody is undergoing Phase I trials in the US and China in subjects with relapsed or refractory MM.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/science/biology/abbvie-and-simcere-zaiming-link-to-develop-trispecific-antibody/ar-AA1xgBc4 ]
Similar Science and Technology Publications
[ Fri, Jan 10th ]: FierceBiotech
[ Thu, Jan 09th ]: MSN
[ Wed, Jan 08th ]: MSN
[ Thu, Jan 02nd ]: MSN
[ Thu, Dec 19th 2024 ]: MSN
[ Mon, Dec 02nd 2024 ]: Tim Hastings
[ Mon, Dec 02nd 2024 ]: Tim Hastings